Cargando…

Gut microbiome alpha-diversity is not a marker of Parkinson’s disease and multiple sclerosis

The gut–brain axis may play a central role in the pathogenesis of neurological disorders. Dozens of case–control studies have been carried out to identify bacterial markers by the use of targeted metagenomics. Alterations of several taxonomic profiles have been confirmed across several populations,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Plassais, Jonathan, Gbikpi-Benissan, Guillaume, Figarol, Marine, Scheperjans, Filip, Gorochov, Guy, Derkinderen, Pascal, Cervino, Alessandra C L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8195527/ https://www.ncbi.nlm.nih.gov/pubmed/34704023 http://dx.doi.org/10.1093/braincomms/fcab113

Ejemplares similares

The Gut and Parkinson’s Disease: Hype or Hope?
por: Scheperjans, Filip, et al.
Publicado: (2018)

Increasing Comparability and Utility of Gut Microbiome Studies in Parkinson’s Disease: A Systematic Review
por: Boertien, Jeffrey M., et al.
Publicado: (2019)

Crosstalk between omega-6 oxylipins and the enteric nervous system: Implications for gut disorders?
por: Mantel, Marine, et al.
Publicado: (2023)

Non-invasive pressure support ventilation (NIPSV) is not very time-consuming for the nursing staff
por: Hilbert, G, et al.
Publicado: (1997)

Gut bacterial tyrosine decarboxylase associates with clinical variables in a longitudinal cohort study of Parkinsons disease
por: van Kessel, Sebastiaan P., et al.
Publicado: (2021)

Valuation of bacteriological quantitative cultures obtained by broncho-alveolar lavages in ventilator-associated pneumonia
por: Gruson, D, et al.
Publicado: (1997)

Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression
por: Aho, Velma T.E., et al.
Publicado: (2019)

Multiomics implicate gut microbiota in altered lipid and energy metabolism in Parkinson’s disease
por: Pereira, Pedro A. B., et al.
Publicado: (2022)

Relationships of gut microbiota, short-chain fatty acids, inflammation, and the gut barrier in Parkinson’s disease
por: Aho, Velma T. E., et al.
Publicado: (2021)

Gut Microbial Diversity Is Reduced in Smokers with Crohn's Disease
por: Opstelten, Jorrit L., et al.
Publicado: (2016)

The Intestinal Barrier in Parkinson’s Disease: Current State of Knowledge
por: van IJzendoorn, Sven C. D., et al.
Publicado: (2019)

Weaning from mechanical ventilation in COPD patients: interest to measure, in post-extubation, the airway occlusion pressure (P0.1), in order to indicate non-invasive pressure support ventilation (NIPSV) to prevent relapse
por: Hilbert, G, et al.
Publicado: (1997)

Gut-microbiome-brain axis: the crosstalk between the vagus nerve, alpha-synuclein and the brain in Parkinson’s disease
por: Claudino dos Santos, Júlio César, et al.
Publicado: (2023)

Irritable Bowel Syndrome and Risk of Parkinson’s Disease in Finland: A Nationwide Registry-Based Cohort Study
por: Mertsalmi, Tuomas H., et al.
Publicado: (2021)

Gut microbiome variation is associated to Multiple Sclerosis phenotypic subtypes
por: Reynders, Tatjana, et al.
Publicado: (2020)

Fecal microbiome alterations in treatment-naive de novo Parkinson’s disease
por: Boertien, Jeffrey M., et al.
Publicado: (2022)

Ecological and economic impact of ceftazidime and probabilist antibiotherapy limitation strategy in ventilator-associated pneumonia
por: Gruson, D, et al.
Publicado: (1997)

Metagenomics of Parkinson’s disease implicates the gut microbiome in multiple disease mechanisms
por: Wallen, Zachary D., et al.
Publicado: (2022)

Alterations of the human gut microbiome in multiple sclerosis
por: Jangi, Sushrut, et al.
Publicado: (2016)

The Role of Diet and Gut Microbiome in Multiple Sclerosis
por: Jayasinghe, Maleesha, et al.
Publicado: (2022)

Feeding the gut microbiome: impact on multiple sclerosis
por: Bronzini, Matteo, et al.
Publicado: (2023)

Motor outcome and electrode location in deep brain stimulation in Parkinson's disease
por: Koivu, Maija, et al.
Publicado: (2018)

Altered Gut Microbiome and Intestinal Pathology in Parkinson’s Disease
por: Chiang, Han-Lin, et al.
Publicado: (2019)

Exploring the multifactorial aspects of Gut Microbiome in Parkinson’s Disease
por: Pavan, Sujith, et al.
Publicado: (2022)

Gut microbiome and Parkinson's disease: Perspective on pathogenesis and treatment
por: Salim, Safa, et al.
Publicado: (2022)

Study of the gut microbiome in Egyptian patients with Parkinson’s Disease
por: Mehanna, Mohammad, et al.
Publicado: (2023)

Gut microbiota composition is associated with narcolepsy type 1
por: Lecomte, Alexandre, et al.
Publicado: (2020)

Host Genetics and Gut Microbiome: Perspectives for Multiple Sclerosis
por: Maglione, Alessandro, et al.
Publicado: (2021)

Gut microbiome is associated with multiple sclerosis activity in children
por: Horton, Mary K., et al.
Publicado: (2021)

Alterations of host-gut microbiome interactions in multiple sclerosis
por: Cantoni, Claudia, et al.
Publicado: (2022)

Gut microbiome composition is associated with long-term disability worsening in multiple sclerosis
por: Devolder, Lindsay, et al.
Publicado: (2023)

Intrapulmonary percussive ventilation in acute exacerbations of COPD patients with mild respiratory acidosis: a randomized controlled trial [ISRCTN17802078]
por: Vargas, Frédéric, et al.
Publicado: (2005)

Biopsable Neural Tissues: Toward New Biomarkers for Parkinson's Disease?
por: Lebouvier, Thibaud, et al.
Publicado: (2010)

Exploring human-genome gut-microbiome interaction in Parkinson’s disease
por: Wallen, Zachary D., et al.
Publicado: (2021)

Nutritional Intake and Gut Microbiome Composition Predict Parkinson’s Disease
por: Lubomski, Michal, et al.
Publicado: (2022)

Therapies for Parkinson’s disease and the gut microbiome: evidence for bidirectional connection
por: Hey, Grace, et al.
Publicado: (2023)

Gut microbiome in multiple sclerosis: The players involved and the roles they play
por: Shahi, Shailesh K., et al.
Publicado: (2017)

The Gut Microbiome in Multiple Sclerosis: A Potential Therapeutic Avenue
por: Kirby, Trevor O., et al.
Publicado: (2018)

The alteration of gut microbiome and metabolism in amyotrophic lateral sclerosis patients
por: Zeng, Qianqian, et al.
Publicado: (2020)

Gut microbiome in systemic sclerosis: a potential therapeutic target
por: Polkowska-Pruszyńska, Beata, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_pofgi3hm6da52qmo02k240vnho